SMTL ID : 4dff.2 (1 other biounit)

The SAR development of dihydroimidazoisoquinoline derivatives as phosphodiesterase 10A inhibitors for the treatment of schizophrenia

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.11 Å

Oligo State

monomer

Ligands

1 x 0JP: 8,9-dimethoxy-1-(1,3-thiazol-5-yl)-5,6-dihydroimidazo[5,1-a]isoquinoline(Non-covalent)

0JP.1: 14 residues within 4Å: Chain A: Y.87, L.198, L.238, S.240, V.241, A.252, I.255, Y.256, F.259, M.276, G.288, Q.289, F.292, Y.293 4 PLIP interactions: 4 interactions with chain A Hydrophobic interactions: A:L.238, A:F.259 Hydrogen bonds: A:Q.289 pi-Stacking: A:F.292

1 x MG: MAGNESIUM ION(Non-covalent)

MG.2: 6 residues within 4Å: Chain A: H.126, D.127, H.130, H.158, T.196 Ligands: ZN.3 6 PLIP interactions: 1 interactions with chain A, 5 Ligand-Water interactions Metal complexes: A:D.127, H2O.1, H2O.1, H2O.1, H2O.1, H2O.1

1 x ZN: ZINC ION(Non-covalent)

ZN.3: 7 residues within 4Å: Chain A: H.88, H.92, V.96, H.126, D.127, D.237 Ligands: MG.2 6 PLIP interactions: 4 interactions with chain A, 2 Ligand-Water interactions Metal complexes: A:H.92, A:H.126, A:D.127, A:D.237, H2O.1, H2O.1

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Ho, G.D. et al., The SAR development of dihydroimidazoisoquinoline derivatives as phosphodiesterase 10A inhibitors for the treatment of schizophrenia. Bioorg.Med.Chem.Lett. (2012)

Release Date

2012-03-14

Peptides

cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A

Related Entries With Identical Sequence